Valuation: Pfizer Inc.

Market Cap 165B 149B 138B 125B 235B 15,526B 243B 1,658B 657B 8,294B 618B 605B 26,327B P/E 2026 *
18.7x
P/E 2027 * 14.3x
Enterprise Value 212B 192B 178B 161B 303B 20,028B 313B 2,139B 848B 10,699B 797B 780B 33,960B EV / Sales 2026 *
3.36x
EV / Sales 2027 * 3.35x
Free-Float
59.05%
Yield 2026 *
5.96%
Yield 2027 * 6%
1 day+0.21%
1 week-1.70%
Current month-5.34%
1 month+1.83%
3 months+7.80%
6 months+11.29%
Current year+16.02%
1 week 28.62
Extreme 28.62
29.77
1 month 28.54
Extreme 28.54
31.44
Current year 23.62
Extreme 23.62
31.44
1 year 23.62
Extreme 23.62
31.44
3 years 20.92
Extreme 20.915
31.54
5 years 20.92
Extreme 20.915
61.71
10 years 20.92
Extreme 20.915
61.71
Manager TitleAgeSince
Chief Executive Officer 64 2018-12-31
Director of Finance/CFO 55 2026-08-15
Compliance Officer 65 2013-11-30
Director TitleAgeSince
Director/Board Member 68 2007-08-31
Director/Board Member 62 2013-09-26
Chairman 64 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/30/26 Free

Chief Executive Officer

20 0.0000%
10/15/26 Free

Chief Executive Officer

20 0.0000%
10/13/26 Free

Chief Executive Officer

71 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.21%-1.70%+12.02%-0.31% 164B
+1.26%+6.61%+41.12%+135.59% 1,271B
+0.79%+3.45%+46.35%+93.56% 683B
+0.20%+1.28%+27.01%+112.80% 520B
-0.44%+3.69%+39.60%+69.51% 389B
+0.55%+0.70%+59.00%+44.20% 362B
-0.12%+0.74%+26.78%+58.43% 304B
+0.37%+0.37%+3.62%+36.44% 286B
-0.30%+1.14%+38.59%+74.61% 253B
+0.08%+0.71%+34.25%+124.32% 208B
Average +0.26%+1.12%+32.83%+74.91% 444B
Weighted average by Cap. +0.52%+2.41%+36.66%+92.52%

Financials

2026 *2027 *
Net sales 63.13B 57.21B 52.91B 47.74B 89.97B 5,952B 93.14B 636B 252B 3,180B 237B 232B 10,093B 60.82B 55.12B 50.98B 46B 86.68B 5,735B 89.73B 612B 243B 3,063B 228B 223B 9,724B
Net income 8.56B 7.76B 7.18B 6.48B 12.21B 808B 12.64B 86.24B 34.19B 431B 32.14B 31.46B 1,369B 11.69B 10.59B 9.8B 8.84B 16.66B 1,102B 17.25B 118B 46.67B 589B 43.87B 42.94B 1,869B
Net Debt 47.74B 43.27B 40.02B 36.11B 68.04B 4,502B 70.44B 481B 191B 2,405B 179B 175B 7,633B 39.17B 35.49B 32.83B 29.62B 55.82B 3,693B 57.79B 394B 156B 1,973B 147B 144B 6,262B
Projected Income Statement - Annual - Pfizer Inc.
Logo Pfizer Inc.
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
75,000
Date Price Change Volume
26-11-13 US$28.89 +0.21% 21,571,917
26-11-12 US$28.83 -2.11% 30,780,121
26-11-11 US$29.45 +0.31% 26,027,922
26-11-10 US$29.36 +0.44% 31,128,745
26-11-09 US$29.23 -0.54% 45,770,041
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Pfizer Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
28.89USD
Average target price
30.22USD
Spread / Average Target
+4.61%